OHIO STATE UNIVERSITY, THE

$567,754

from Department of Health and Human Services · National Institutes of Health

IMMUNOTHERAPY FOR GLIOBLASTOMA BY TARGETING AN IMMUNOREGULATORY NEUROPEPTIDE - LIOBLASTOMA (GBM) IS THE MOST LETHAL PRIMARY BRAIN TUMOR, MARKED BY LIMITED TREATMENT OPTIONS AND POOR SURVIVAL. GBM IS ALSO REMARKABLY RESISTANT TO IMMUNOTHERAPY DUE TO CD8⁺ T CELL EXCLUSION AND DYSFUNCTION, LARGELY DRIVEN BY IMMUNOSUPPRESSIVE MYELOID CELLS—PARTICULARLY TUMOR-ASSOCIATED MACROPHAGES (TAMS). THIS POSI...
Description as recorded in the federal award record (cut at 400 characters).

Award ID: R01CA304655
Award type: PROJECT GRANT (B)
First obligated: Jun 25, 2026
Period starts: Jun 23, 2026
Place of performance: Franklin County, Ohio 43210
Assistance listing: 93.395 CANCER TREATMENT RESEARCH
Amount means: Federal obligation for this grant, as of our last read Oct 13, 2026.

Open the full record on USAspending.gov More in Franklin County

Copied from USAspending.gov. Where It Lands is not a government site and is not affiliated with USAspending.gov or the awarding agency.